Tom Dodson President of Romet Electronic Larynx proudly announces that Romet has entered exclusive distribution arrangements for all Romet Laryngectomee products in Vietnam and Mexico.
For ENT practitioners looking to offer patients additional emotional support and links to a reliable peer network, the Hearpeers community and its volunteer mentors are now available globally.
Cl-ear, the fastest growing ear care brand of drops and spray¹, welcomes Mr Neel Raithatha, Consultant Audiologist BSc (Hons), RHAD, MSHAA, The Wax Whisperer, as healthcare advisor.
Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnoea (OSA), primarily due to the vast amount of short-term evidence in the medical literature it has accrued. The enduring obstacle to CPAP from becoming a treatment option...
The claim made in the title of this paper, that hemithyroidectomy is equally as successful as total thyroidectomy in alleviating compressive symptoms from goitres, is certainly intriguing. And with the inclusion of 45,539 subjects, it would at first glance seem...
MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.
The study notes that the pure tone audiogram has been the primary clinical and counselling tool used by clinicians to assess and describe hearing thresholds to individuals and families since 1922. The Ida Institutes, ‘My Hearing Explained’ tool has become...
Common Terminology Criteria for Adverse Events (CTCAE) is a system used by clinicians to grade the toxicity of oncology treatments in a standardised manner. Dysphagia is perhaps the most common long-term toxicity of head and neck cancer treatment. Currently, a...
Authors suggest there is little evidence that hearing technology addresses patients’ emotional concerns related to their lived experience of hearing and communication difficulty. The study explores the notion of audiologic counselling and discusses the role of audiologists in supporting the...
In line with the announcement from Boston Scientific informing customers that they will cease global production of the Lumenis range of CO2 lasers at the end of 2024, Carleton Medical Ltd wish to reassure continuation of service.
Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.